Granules Pharmaceuticals is recalling approximately 478,173 bottles of Metformin Hydrochloride Extended-Release Tablets (750 mg), a medication used to treat type 2 diabetes. The recall includes both 100-count and 500-count bottles that were distributed nationwide across the United States. This action was taken because FDA testing detected levels of N-Nitrosodimethylamine (NDMA) that exceed the acceptable daily intake limit. Consumers should continue taking their medication until they speak with a healthcare provider, as stopping diabetes medication suddenly can pose serious health risks.
The tablets contain NDMA, a substance classified as a probable human carcinogen based on laboratory tests. While NDMA is a common environmental contaminant found in water and foods, long-term exposure to levels above acceptable limits may increase the risk of developing cancer.
Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.